Attached files

file filename
EX-10.44 - AUGUST 21, 2019 EMPLOYMENT AGREEMENT BETWEEN KBL MERGER CORP. IV AND JONATHAN RO - 180 Life Sciences Corp.f10k2020ex10-44_180lifescien.htm
EX-4.6 - DESCRIPTION OF THE REGISTRANT'S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF - 180 Life Sciences Corp.f10k2020ex4-6_180lifescien.htm
EX-99.4 - RISK, SAFETY AND REGULATORY COMMITTEE CHARTER - 180 Life Sciences Corp.f10k2020ex99-4_180lifescien.htm
EX-32.2 - CERTIFICATION - 180 Life Sciences Corp.f10k2020ex32-2_180lifescien.htm
EX-32.1 - CERTIFICATION - 180 Life Sciences Corp.f10k2020ex32-1_180lifescien.htm
EX-31.2 - CERTIFICATION - 180 Life Sciences Corp.f10k2020ex31-2_180lifescien.htm
EX-31.1 - CERTIFICATION - 180 Life Sciences Corp.f10k2020ex31-1_180lifescien.htm
10-K - ANNUAL REPORT - 180 Life Sciences Corp.f10k2020_180lifesciences.htm

Exhibit 21.1

 

Direct and Indirect Subsidiaries of 180 Life Sciences Corp.*

 

LIST OF SUBSIDIARIES

 

Name   Jurisdiction of Incorporation  
180 Life Corp.   Delaware  
Katexco Callco ULC   British Columbia  
CannBioRex Callco ULC   British Columbia  
180 Therapeutics LP   Delaware  
Katexco Purchaseco ULC   British Columbia  
CannBioRex Purchaseco ULC   British Columbia  
Katexco Pharmaceuticals Corp.   British Columbia  
CannBioRex Pharmaceuticals Corp.   British Columbia  
Katexco Pharmaceuticals Corp.   California  
CannBioRex Pharma Limited   United Kingdom  

 

 

*Pursuant to Item 601(b)(21)(ii) of Regulation S-K, the names of other subsidiaries of 180 Life Sciences Corp. are omitted because, considered in the aggregate, they would not constitute a significant subsidiary as of the end of the year covered by this report. Inclusion in this list is not, however, a representation that the listed subsidiary is a “significant subsidiary.”